602P - Epidemiology of colorectal cancer in Korea: Korean National Health insurance bigdata analysis

Date 09 September 2017
Event ESMO 2017 Congress
Session Poster display session
Topics Cancer Aetiology, Epidemiology, Prevention
Colon Cancer
Rectal Cancer
Gastrointestinal Cancers
Presenter Sang-Cheol Lee
Citation Annals of Oncology (2017) 28 (suppl_5): v158-v208. 10.1093/annonc/mdx393
Authors S.K. Baek1, J.S. Lee2, H.J. Ha3, S. Lee4, S. Bae5, I.G. Hwang6, J.G. Kim7, T.W. Kim8
  • 1Internal Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine, 130-702 - Seoul/KR
  • 2Clinical Research Center, Asan Medical Cencer, - - Seoul/KR
  • 3Internal Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul/KR
  • 4Internal Medicine, Soonchunhyang University Hospital, - - Cheonan/KR
  • 5Internal Medicine, Soonchunhyang University Hospital, Cheonan/KR
  • 6Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul/KR
  • 7Oncology/hematology, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Daegu/KR
  • 8Oncology, Asan Medical Center, University of Ulsan College of Medicine, 05505 - Seoul/KR

Abstract

Background

This study was conducted to demonstrate the epidemiology of colorectal cancer (CRC) in Korea using the by analysis of big data using the Korean National Health Insurance Service (NHIS).

Methods

We analyzed the NHIS database of patients admitted hospitals which received its quality assessment of CRC between 2011 and 2014.

Results

We included 71,513 colorectal cancer patients. Median follow-up duration was 3.2 years (range 0.003-5.5 years). Male patients were 60.1% and median age was 65 years old (interqurtile range 56-73). The stage at diagnosis was stage I in 22.0%, stage II 29.0%, stage III 35.6%, stage IV 12.9%. As primary site according to surgery code, colon is 61.7% and rectum is 38.3%. Patients with adenocarcinoma were 96.5%. Survival probability at 5 year elderly patients (³ 70 years old) showed worse survival rate than that of patient with age

Conclusions

These results show epidemiology and survival of CRC in Korea. Our study was the first to describe these data for colorectal cancer at a nationwide level.

Clinical trial identification

Legal entity responsible for the study

Sun Kyung Baek

Funding

None

Disclosure

All authors have declared no conflicts of interest.